These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37722198)

  • 1. Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study.
    Grubman D; Ahmad Y; Leipsic JA; Blanke P; Pasupati S; Webster M; Nazif TM; Parise H; Lansky AJ
    Am J Cardiol; 2023 Nov; 207():28-34. PubMed ID: 37722198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.
    Seeger J; Virmani R; Romero M; Gonska B; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1683-1693. PubMed ID: 30154060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement.
    Danenberg H; Vaknin-Assa H; Makkar R; Virmani R; Manevich L; Codner P; Patel V; Finn AV; Landes U; Rubinshtein R; Bar A; Barnea R; Mezape Y; Teichman E; Eli S; Weisz G; Kornowski R
    EuroIntervention; 2023 Dec; 19(11):e948-e952. PubMed ID: 37916296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.
    Kapadia SR; Kodali S; Makkar R; Mehran R; Lazar RM; Zivadinov R; Dwyer MG; Jilaihawi H; Virmani R; Anwaruddin S; Thourani VH; Nazif T; Mangner N; Woitek F; Krishnaswamy A; Mick S; Chakravarty T; Nakamura M; McCabe JM; Satler L; Zajarias A; Szeto WY; Svensson L; Alu MC; White RM; Kraemer C; Parhizgar A; Leon MB; Linke A;
    J Am Coll Cardiol; 2017 Jan; 69(4):367-377. PubMed ID: 27815101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.
    Van Mieghem NM; El Faquir N; Rahhab Z; Rodríguez-Olivares R; Wilschut J; Ouhlous M; Galema TW; Geleijnse ML; Kappetein AP; Schipper ME; de Jaegere PP
    JACC Cardiovasc Interv; 2015 Apr; 8(5):718-24. PubMed ID: 25946445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
    Rossow CF; McCabe JM
    Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of embolic debris captured during transcatheter aortic valve replacement.
    Van Mieghem NM; Schipper ME; Ladich E; Faqiri E; van der Boon R; Randjgari A; Schultz C; Moelker A; van Geuns RJ; Otsuka F; Serruys PW; Virmani R; de Jaegere PP
    Circulation; 2013 Jun; 127(22):2194-201. PubMed ID: 23652860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.